Minerva Neurosciences (NERV) Cash from Operations (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Cash from Operations data on file, last reported at 5400000.0 in Q1 2026.

• Quarterly Cash from Operations fell 32.61% year-over-year to 5400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14828040.0 (up 15.4% YoY) and the FY2025 annual result came in at 13500000.0, up 30.95% from the prior year.
• Cash from Operations fell to 5400000.0 in Q1 2026, from 4500000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 115407.0 in Q1 2023 to a low of 9533990.0 in Q3 2022.
• A 5-year average of 4581202.47 and a median of 4500000.0 in 2025 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2023 — Cash from Operations soared 98.01% — and 2024, when it slumped 5180.68%.
• Tracing NERV's Cash from Operations over 5 years: stood at 4110076.0 in 2022, then slumped by 45.77% to 5991385.0 in 2023, then grew by 13.76% to 5166784.0 in 2024, then advanced by 12.91% to 4500000.0 in 2025, then slipped by 20.0% to 5400000.0 in 2026.
• The last three Cash from Operations figures came in at 5400000.0 (Q1 2026), 4500000.0 (Q4 2025), and 2885902.0 (Q3 2025), per Business Quant data.